Search results for "DASE"

showing 10 items of 1891 documents

Towards a poïetic of are or the stakes of a new interpretation of the being : the possibilities and the limits of the renewal of the Metaphysics from…

2012

The “being” remains still and always today an extremely mysterious and polemic object for the philosophers as for the individual who we are. Face to the perpetual reappearance of this object in the form of a fundamental interrogation, the question is to know if we are confronted to an insoluble problem for the reason or if it is a methodological problem which it is advisable to raise. Beyond of a new attempt at destruction of Metaphysics in all its forms and its dimensions by the postmoderns, we must try to reflect today on the true positivity of the questioning of the “being”. From Kant to Bachelard, we are seeing a gradual opening during the history through the way of another practice whi…

ArchetypeIndividuArchétypeImaginaryÉtant[SHS.PHIL]Humanities and Social Sciences/PhilosophyBeingIndividualÊtrePsychoanalysisCriticalDasein[SHS.PHIL] Humanities and Social Sciences/Philosophy[ SHS.PHIL ] Humanities and Social Sciences/PhilosophyPoïeticImaginationPoeticPoétiqueCritiquePoïétiqueImaginaire
researchProduct

Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages.

1998

Abstract —The mechanisms underlying the selective accumulation of macrophages in early atherosclerotic lesions are poorly understood but are likely to be related to specific properties of altered low density lipoprotein (LDL) deposited in the subendothelium. Enzymatic, nonoxidative degradation of LDL converts the lipoprotein to a potentially atherogenic moiety, enzymatically altered LDL (E-LDL), which activates complement and is rapidly taken up by human macrophages via a scavenger receptor–dependent pathway. Immunohistological evidence indicates that E-LDL is present in an extracellular location in the early lesion. We report that E-LDL causes massive release of monocyte chemotactic prote…

ArteriosclerosisHydrolasesGene ExpressionNeuraminidaseBiologyCCL2Polymerase Chain Reactionchemistry.chemical_compoundExtracellularmedicineMacrophageHumansTrypsinInterleukin 8RNA MessengerCells CulturedChemokine CCL2Cell DeathMonocyteMacrophagesRNA-Directed DNA PolymeraseSterol EsteraseMolecular biologyLipoproteins LDLKineticsmedicine.anatomical_structureBiochemistrychemistryApoptosisLow-density lipoproteinlipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineLipoproteinArteriosclerosis, thrombosis, and vascular biology
researchProduct

An active form of sphingosine kinase-1 is released in the extracellular medium as component of membrane vesicles shed by two human tumor cell line.

2010

Expression of sphingosine kinase-1 (SphK-1) correlates with a poor survival rate of tumor patients. This effect is probably due to the ability of SphK-1 to be released into the extracellular medium where it catalyzes the biosynthesis of sphingosine-1-phosphate (S1P), a signaling molecule endowed with profound proangiogenic effects. SphK-1 is a leaderless protein which is secreted by an unconventional mechanism. In this paper, we will show that in human hepatocarcinoma Sk-Hep1 cells, extracellular signaling is followed by targeting the enzyme to the cell surface and parallels targeting of FGF-2 to the budding vesicles. We will also show that SphK-1 is present in a catalitycally active form i…

Article SubjectNeutral CeramidasebiologySphingosineVesicleCellmembrane vesicleslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensSphK vesicleslcsh:RC254-282Cell biologychemistry.chemical_compoundmedicine.anatomical_structureOncologySphingosine kinase 1chemistryBiosynthesisCell cultureSettore BIO/10 - Biochimicabiology.proteinExtracellularmedicinesphingosine kinase; ceramidase; tumoe cells. microvesiclesResearch Article
researchProduct

The Expression of an Immune-Related Phenoloxidase Gene is Modulated in Ciona Intestinalis Ovary, Test Cells, Embryos and Larva

2015

Two distinct Ciona intestinalis phenoloxidases (CinPO1, 2) had previously been cloned and sequenced. The CinPO2 is involved in innate immunity and is expressed by inflammatory hemocytes that populate the tunic and pharynx vessels as a response to LPS inoculation. In situ hybridization and immunohistochemistry assays on histological section, showed that the expression of this gene and the produced protein are shared with oogenesis, embryogenesis and larval morphogenesis. Intriguingly, upregulation of gene transcription was found in the test cell layer that envelopes the ovary follicle, ovulated egg, and gastrula, as well as it was modulated in the zygotic nucleus of outer balstomers of 32-ce…

Ascidians development immunity phenoloxidase
researchProduct

Protease A activity and nitrogen fractions released during alcoholic fermentation and autolysis in enological conditions

2000

Determination of protease A activity during alcoholic fermentation of a synthetic must (pH 3.5 at 25 degrees C) and during autolysis showed that a sixfold induction of protease A activity occurred after sugar exhaustion, well before 100% cell death occurred. A decrease in protease A activity was observed when yeast cell autolysis started. Extracellular protease A activity was detected late in the autolysis process, which suggests that protease A is not easily released. Evolution of amino acids and peptides was determined during alcoholic fermentation and during autolysis. Amino acids were released in early stationary phase. These amino acids were subsequently assimilated during the fermenta…

Autolysis (biology)Saccharomyces cerevisiae ProteinsTime FactorsNitrogenmedicine.medical_treatmentWineBioengineeringPeptideSaccharomyces cerevisiaeEthanol fermentationBiologyApplied Microbiology and BiotechnologymedicineAspartic Acid EndopeptidasesAmino AcidsChromatography High Pressure Liquidchemistry.chemical_classificationProteaseCell autolysisTemperatureHydrogen-Ion ConcentrationYeastAmino acidBiochemistrychemistryAlcoholsFermentationFermentationAutolysisBiotechnologyJournal of Industrial Microbiology and Biotechnology
researchProduct

Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoG…

2019

This multicenter/multinational, open-label, ascending-dose study (NCT01898364) evaluated safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of repeat-dose avalglucosidase alfa (neoGAA), a second-generation, recombinant acid α-glucosidase replacement therapy, in late-onset Pompe disease (LOPD). Patients ≥18 years, alglucosidase alfa naïve (Naïve) or previously receiving alglucosidase alfa for ≥9 months (Switch), with baseline FVC ≥50% predicted and independently ambulatory, received every-other-week avalglucosidase alfa 5, 10, or 20 mg/kg over 24 weeks. 9/10 Naïve and 12/14 Switch patients completed the study. Avalglucosidase alfa was well-tolerated; no deaths…

Avalglucosidase alfa (neoGAA)0301 basic medicineMaleGLUCOSE TETRASACCHARIDELysosomal acid alpha-glucosidase (GAA) deficiencyCHILDRENPulmonary function testingMOTOR FUNCTION0302 clinical medicineMedicineGenetics (clinical)Late-onset Pompe disease (LOPD)Glycogen Storage Disease Type IIAlglucosidase alfaMOUSE MODELEnzyme replacement therapyMiddle AgedTreatment OutcomeNeurologyTolerabilityEnzyme replacement therapySKELETAL-MUSCLEFemaleLife Sciences & BiomedicineMUSCLE TRAINING RMTGlycogen6-MINUTE WALKmedicine.drugAdultmedicine.medical_specialtyClinical NeurologyGLYCOGEN03 medical and health sciencesFEV1/FVC ratioPharmacokineticsInternal medicineHumansEnzyme Replacement TherapyAdverse effectAlglucosidase alfaScience & Technologybusiness.industryNeurosciencesalpha-GlucosidasesADULTSGlycogen storage disease type IISEVERITY030104 developmental biologyPharmacodynamicsPediatrics Perinatology and Child HealthNeurosciences & NeurologyNeurology (clinical)Glucan 14-alpha-Glucosidasebusiness030217 neurology & neurosurgeryNeuromuscular Disorders
researchProduct

Evaluation of yeasts from Ecuadorian chicha by their performance as starters for alcoholic fermentations in the food industry

2020

Yeasts involved in the spontaneous fermentation of traditional beverages like chicha (indigenous Andean beer) may have the potential to be used as starter cultures to improve the quality and microbiological safety of these products, but also as non-conventional alternatives to other food alcoholic fermentations. In this research, we isolated, identified and characterised yeast strains from four Ecuadorian chichas made by using four different raw materials: rice (RC), oat (OC), grape (GC) and a mixture of seven corn varieties (yamor, YC). Finally, 254 yeast isolates were obtained and identified by molecular methods. Eleven yeast genera and 16 yeast species were identified with relatively few…

AvenaFood industryFermentative capacitySaccharomyces cerevisiaeWineSaccharomyces cerevisiaeZea maysMicrobiology03 medical and health sciencesStarterTorulaspora delbrueckiiYeastsFood IndustryVitisIndigenous Andean beverageAmylaseFood science030304 developmental biologyWine0303 health sciencesbeta-Fructofuranosidasebiology030306 microbiologybusiness.industryBeerfood and beveragesOryzaTorulasporaGeneral Medicinebiology.organism_classificationYeastYeast dry starterFermentationbiology.proteinFermentationNon-Saccharomyces yeastsEcuadorbusinessFood Science
researchProduct

Efficacy of the antioxidant ebselen in experimental uveitis.

1999

Inflammation results in the production of free radicals. In a model of experimental uveitis upon subcutaneous injection of endotoxin to Lewis rats, i.e., endotoxin-induced experimental uveitis (EIU), we have evaluated the status of the antioxidant capacity of ocular tissues. EIU results in a decrease of glutathione (GSH) content and glutathione peroxidase (GPx) activity in whole eye homogenates 24-h after endotoxin administration. Furthermore, an increase in malondialdehyde (MDA) content was observed in these same samples, thus confirming the involvement of oxidative stress in the pathophysiology of the process. In view of the ability of the antioxidant ebselen as GPx enzyme mimic, we teste…

AzolesAntioxidantFree Radicalsmedicine.medical_treatmentDrug Evaluation PreclinicalPharmacologyIsoindolesmedicine.disease_causeBiochemistryAntioxidantsUveitischemistry.chemical_compoundSubcutaneous injectionPhysiology (medical)MalondialdehydeOrganoselenium CompoundsmedicineEscherichia coliAnimalschemistry.chemical_classificationGlutathione PeroxidaseEbselenGlutathione peroxidaseAnti-Inflammatory Agents Non-SteroidalGlutathioneMalondialdehydeGlutathioneeye diseasesRatsEndotoxinsBiochemistrychemistryRats Inbred Lewsense organsPeroxynitriteOxidative stressFree radical biologymedicine
researchProduct

Some aspects of cardiac antioxidant defence: Ebselen (PZ 51) treatment increases glutathione peroxidase activity in the rat heart

1990

Ebselcn (PZ 5 1 : 2-phenyl1.2-benzisoelenazol-3-( 2H)-one 1 is ii synthetic organoselenium compound with anti-inflammatory activity ( I . 21, which exhibits glutathione peroxidase (GSH-Px)-like activity, catalysing the reduction o f hydrogen peroxide as well as other organic peroxides [3-5]. Its antiinflammatory effect may be mediated by either the GSH-Px activity, the inhibition of leukotriene B4 formation [6], the antioxidant capacity, or a combination of all of them. Many attempts have been made to increase the antioxidant capacity of the myocardium, since free radical generation has been demonstrated in ischaemia-reperfusion damage [7, 81; superoxide dismutase (SOD) and catalase have be…

AzolesAntioxidantmedicine.medical_treatmentMyocardial Reperfusion InjuryIsoindolesPharmacologyBiochemistryAntioxidantsSuperoxide dismutaseSeleniumchemistry.chemical_compoundOrganoselenium CompoundsmedicineAnimalsHydrogen peroxidechemistry.chemical_classificationGlutathione PeroxidasebiologyChemistryEbselenMyocardiumGlutathione peroxidaseHeartRats Inbred StrainsGlutathioneRatsBiochemistryCatalasebiology.proteinPeroxidase
researchProduct

Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen.

2002

This study was aimed at examining the role of oxygen and nitrogen reactive species in a model of experimental uveitis upon intravitreal injection of bacterial endotoxin to albino New Zealand rabbits. The inflammatory response was evaluated in terms of: (i) the integrity of the blood aqueous barrier (protein and cell content in samples of aqueous humor), (ii) histopathological changes of the eyes, (iii) clinical evaluation (with a score index based on clinical symptoms), and (iv) the concentration of malondialdehyde (MDA), in aqueous humor, as a marker of oxidative stress. Betamethasone was used as reference treatment, superoxide dismutase as quencher of superoxide anion, L-N(G)-nitro-L-argi…

AzolesFree RadicalsChlorpromazineAnti-Inflammatory AgentsPharmacologyIsoindolesmedicine.disease_causeBiochemistryAntioxidantsSuperoxide dismutaseUveitischemistry.chemical_compoundPhysiology (medical)MalondialdehydeOrganoselenium CompoundsmedicineAnimalsEnzyme InhibitorsReactive nitrogen specieschemistry.chemical_classificationReactive oxygen speciesbiologyChemistrySuperoxideEbselenSuperoxide DismutaseGlutathione peroxidaseMalondialdehydeReactive Nitrogen SpeciesDisease Models AnimalNG-Nitroarginine Methyl EsterBiochemistrybiology.proteinLipid PeroxidationRabbitsNitric Oxide SynthaseReactive Oxygen SpeciesOxidative stressFree radical biologymedicine
researchProduct